April 5, 2017 / 12:38 PM / 4 months ago

BRIEF-Sanofi appoints Bill Sibold as executive vice president for Sanofi Genzyme

1 Min Read

April 5 (Reuters) - Sanofi:

* Appoints Bill Sibold as Executive Vice President Sanofi Genzyme, effective July 1, 2017

* Sibold currently serves as head of Sanofi Genzyme's Global Multiple Sclerosis, Oncology and Immunology organization, a position he has held since January 2016 and where he has led preparation for the global launches of Dupilumab and Sarilumab

* Sibold will now lead the company's efforts to maintain its leadership in rare diseases while continuing to grow in multiple sclerosis, oncology and immunology, company adds in statement

Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below